Rani Therapeutics director reports 12,500-share option
Michelle Gilson, a director of Rani Therapeutics Holdings, Inc., reports beneficial ownership of a stock option covering 12,500 shares of Class A Common Stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Michelle Gilson, a director of Rani Therapeutics Holdings, Inc., reports beneficial ownership of a stock option covering 12,500 shares of Class A Common Stock. The option has an exercise price of $7.46 per share, expires on October 30, 2026, is fully vested and exercisable, and is held directly.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Gilson Michelle
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Stock Option (right to buy) F1 | -- | -- | -- |
Holdings:
Stock Option (right to buy) — 12,500 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option are fully vested and exercisable.
Key Figures
Underlying shares: 12,500 shares
Exercise price: $7.46 per share
Option expiration date: 2026-10-30
3 metrics
Underlying shares
12,500 shares
Stock Option (right to buy) for Class A Common Stock
Exercise price
$7.46 per share
Exercise price of reported stock option
Option expiration date
2026-10-30
Expiration date of the stock option
Key Terms
Stock Option (right to buy), Class A Common Stock, beneficial ownership, fully vested and exercisable
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy) for 12,500 shares"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock underlying the option"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
beneficial ownership financial
"initial statement of beneficial ownership of securities by a director"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
fully vested and exercisable financial
"footnote: The shares subject to the option are fully vested and exercisable"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider position did Michelle Gilson report for RANI on this Form 3?
Michelle Gilson reported a stock option covering 12,500 shares of Rani Therapeutics’ Class A Common Stock, held directly as part of her beneficial ownership as a director.
What is the exercise price of Michelle Gilson’s RANI stock option?
The reported stock option has an exercise price of $7.46 per share. This price is the cost per share to convert the option into Class A Common Stock before expiration.
When does Michelle Gilson’s reported RANI stock option expire?
The stock option reported by Michelle Gilson expires on October 30, 2026. She may exercise the option any time before this expiration date, subject to applicable plan and company rules.
Are Michelle Gilson’s RANI stock options vested according to this Form 3?
Yes. A footnote states the shares subject to the option are fully vested and exercisable, meaning they are currently available to be exercised into Class A Common Stock.
Is Michelle Gilson’s ownership of the RANI option direct or indirect?
The Form 3 classifies the ownership as direct. This indicates the stock option is held in her own name rather than through a trust, fund, or other indirect entity.
Does this RANI Form 3 show any stock purchases or sales by Michelle Gilson?
No. The report lists a holding entry for a stock option only, with no recorded buy or sell transactions and no change in share ownership indicated.
AI-generated analysis. How Rhea-AI works. Not financial advice.
